Meinong Biotech (301156.SZ) announced first-half results, with net profit of 18.061 million yuan to mother, a year-on-year decrease of 23.23%

According to the Zhitong Finance App, Meinong Biotech (301156.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 328 million yuan, an increase of 38.71% over the previous year. Net profit attributable to shareholders of listed companies was RMB 18.061 million, a year-on-year decrease of 23.23%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 177.64,900 yuan, a year-on-year decrease of 18.66%.